IL-1β is regulated by the IL-1RI/NF-κB pathway and is a tumor-related factor leading to MDSC amplification and migration (Cervantes-Villagrana et al., 2020; Kuo et al., 2021). The gene discussed is IL1B; the disease is neoplasm.